| Net Cash Provided by (Used in) Operating Activities |
-22.1K |
USD |
|
Q3 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
24K |
USD |
+140% |
Q3 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q3 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
250M |
shares |
0% |
Q2 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
1.27M |
shares |
0% |
Q2 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
1.86K |
USD |
-81.4% |
Q3 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
12.1K |
USD |
+88.4% |
Q2 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q3 2023 |
Q1 2024 |
| Deferred Tax Assets, Valuation Allowance |
2.45M |
USD |
-0.63% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
2.45M |
USD |
-0.41% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
100K |
shares |
0% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2025 |
FY 2025 |
| Additional Paid in Capital |
11.6M |
USD |
+0.71% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
100K |
shares |
0% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
2.45M |
USD |
-0.63% |
Q2 2025 |
FY 2025 |
| Interest Expense |
252 |
USD |
-59.6% |
Q1 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
FY 2025 |